The impact of cardiovascular diseases on maternal deaths in the Nordic countries

Lill T Nyfløt1,2, Marianne Johansen3, Ajlana Mulic-Lutvica4

  • 1Norwegian Research center for Women's Health, Oslo University Hospital, Oslo, Norway.

Insights

Cardiovascular diseases are the leading cause of maternal death in Nordic countries. Increased awareness of cardiac symptoms in pregnant women is crucial for preventing future deaths.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular diseases (CVDs) are a growing concern in maternal mortality in Nordic countries.
  • This trend is linked to an increasing number of pregnancies with pre-existing or newly developed heart conditions.
  • Audits are essential for identifying causes of death and improving clinical management to prevent maternal fatalities.

Purpose of the Study:

  • To analyze maternal deaths in Nordic countries between 2005 and 2017.
  • To identify the primary causes of maternal mortality, focusing on cardiovascular diseases.
  • To evaluate the quality of clinical care and identify areas for improvement.

Main Methods:

  • Utilized linked national registers to identify maternal deaths from 2005 to 2017.
  • Conducted case assessments using hospital records by national audit groups.
  • Classified causes of death and assessed the standard of clinical care provided.

Main Results:

  • Identified 227 maternal deaths, with a mortality rate of 5.98 per 100,000 live births.
  • Cardiovascular disease was the most frequent cause of death (n=36), including aortic dissection/rupture, myocardial disease, and ischemic heart disease.
  • In almost 60% of cases, the cardiovascular disease was undiagnosed before death; substandard care was noted in 59% of deaths.

Conclusions:

  • Cardiovascular diseases were the leading cause of maternal deaths in the Nordic region from 2005 to 2017.
  • There is significant potential to reduce maternal mortality by addressing cardiovascular-related deaths.
  • Enhanced recognition of cardiac symptoms in pregnant individuals is recommended to improve outcomes.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
181
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
669
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.3K
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
967
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
2.0K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
586